During chemotherapy treatments, hair loss represents a particularly traumatic side effect for patients. Every year, thousands of people find themselves facing this painful physical change, which profoundly impacts their image and self-esteem. The Irish start-up Luminate Medical, with the Lily helmet, promises a solution to significantly reduce this problem.
A helmet that stops hair loss during chemotherapy
The Lily helmet, developed by Luminate Medical, applies even pressure to the scalp, blocking the flow of chemotherapy drugs to the hair follicles. This non-invasive approach can be used in the comfort of home, with results showing a reduction in hair loss of up to 75%. According to Aaron Hannon, CEO of Luminate Medical, initial testing showed that patients who completed multiple chemotherapy sessions maintained abundant hair, with positive feedback highlighting the improvement in their treatment experience.
The company has carried out numerous clinical tests that demonstrate not only the effectiveness of the device, but also the absence of significant side effects. Although the Lily helmet has not yet received FDA approval, Luminate Medical is confident that certification is imminent. The future of the Lily helmet also includes expanding home use, making this innovative approach for cancer patients even easier and more accessible.